NYSE - Nasdaq Real Time Price USD

Thermo Fisher Scientific Inc. (TMO)

Compare
513.08 -19.94 (-3.74%)
At close: November 15 at 4:00 PM EST
516.66 +3.58 (+0.70%)
After hours: November 15 at 7:41 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Marc N. Casper Chairman, President & CEO 5.08M 47.09M 1968
Mr. Stephen Williamson Senior VP & CFO 2.02M 10.57M 1967
Mr. Michel Lagarde Executive VP & COO 2.22M -- 1975
Ms. Lisa P. Britt Chief Human Resources Officer & Senior VP 1.21M -- 1968
Mr. Gianluca Pettiti Executive Vice President 1.66M 911.34k 1979
Mr. Joseph R. Holmes VP & Chief Accounting Officer -- -- 1980
Mr. Ryan J. Snyder Senior VP & Chief Information Officer -- -- --
Dr. Karen E. Nelson Ph.D. Chief Scientific Officer -- -- --
Mr. Rafael Tejada Vice President of Investor Relations -- -- --
Mr. Michael A. Boxer Esq. Senior VP & General Counsel 1.76M 2.9M 1962

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451
United States
781 622 1000 https://www.thermofisher.com
Sector:?
Healthcare
Full Time Employees:?
122,000

Description

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Corporate Governance

Thermo Fisher Scientific Inc.’s ISS Governance QualityScore as of November 1, 2024 is 3. The pillar scores are Audit: 5; Board: 7; Shareholder Rights: 1; Compensation: 4.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

December 13, 2024 at 12:00 AM UTC

Ex-Dividend Date

January 15, 2025 at 12:00 AM UTC

Dividend Date

January 31, 2025 at 10:59 AM UTC - February 5, 2025 at 12:00 PM UTC

Thermo Fisher Scientific Inc. Earnings Date

Recent Events

November 1, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 23, 2024 at 12:30 PM UTC

Q3 2024 Earnings Call

October 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 19, 2024 at 1:00 PM UTC

Thermo Fisher Scientific to Host Investor Day

September 5, 2024 at 12:30 PM UTC

at Morgan Stanley Global Healthcare Conference

August 2, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 24, 2024 at 12:30 PM UTC

Q2 2024 Earnings Call

July 24, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 17, 2024 at 12:00 AM UTC

SC TO-T/A: Tender Offer/Acquisition Reports

July 10, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers